FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

13 results

diazoxide
(Diazoxide)
Par Pharmaceutical, Inc
Usage: Diazoxide oral suspension is indicated for managing hypoglycemia due to hyperinsulinism, including conditions like inoperable islet cell tumors and certain pediatric disorders. It is used when other treatments fail or are not viable, both preoperatively and postoperatively for persistent hypoglycemia.
ethacrynate sodium
(ETHACRYNATE SODIUM)
Leading Pharma, LLC
Usage: Ethacrynic acid is indicated for treating edema in conditions such as congestive heart failure, liver cirrhosis, and renal disease. It is also used for short-term management of malignancy-related ascites, idiopathic edema, and pediatric patients with specific heart conditions, particularly when rapid diuresis is needed.
ethacrynic acid
(Ethacrynic acid)
TRUPHARMA LLC
Usage: Ethacrynic Acid Tablets are indicated for treating edema requiring potent diuresis, associated with conditions like congestive heart failure, liver cirrhosis, and renal disease. They are also used for managing ascites, idiopathic edema, and lymphedema, and for hospitalized pediatric patients with specific conditions. Intravenous forms are for rapid diuresis.
fludeoxyglucose
(Fludeoxyglucose F-18)
Biomedical Research Foundation of Northwest Louisiana
Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging in oncology for assessing malignancy, in cardiology for evaluating heart function in coronary artery disease, and in neurology for identifying areas of abnormal glucose metabolism related to epileptic seizures.
fludeoxyglucose f 18
(Fludeoxyglucose F 18)
PETNET Solutions, Inc.
Usage: Fludeoxyglucose F 18 Injection is used for PET imaging in oncology to assess glucose metabolism in malignancies, in cardiology to evaluate left ventricular function in coronary artery disease, and in neurology to identify abnormal glucose metabolism related to epileptic seizures.
fludeoxyglucose f 18
(Fludeoxyglucose F-18)
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Usage: Fludeoxyglucose F18 Injection is indicated for PET imaging in oncology to assess abnormal glucose metabolism in malignancy, in cardiology to identify myocardial glucose metabolism in coronary artery disease, and in neurology to locate abnormal glucose metabolism related to epileptic seizures.
fludeoxyglucose f 18
(Fludeoxyglucose F-18)
SOFIE Co.
Usage: Fludeoxyglucose F18 Injection is indicated for PET imaging in oncology to evaluate malignancy, in cardiology to assess glucose metabolism in coronary artery disease, and in neurology to identify abnormal glucose metabolism related to epileptic seizures.
fludeoxyglucose f 18
(Fludeoxyglucose F-18)
Mayo Clinic
Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging to assess abnormal glucose metabolism in oncology for malignancy evaluation, in cardiology for identifying reversible left ventricular dysfunction in coronary artery disease, and in neurology to locate abnormal glucose metabolism related to epileptic seizures.
fludeoxyglucose f-18
(FLUDEOXYGLUCOSE F-18)
Precision Nuclear, LLC
Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging in oncology to assess glucose metabolism in malignancies, in cardiology for identifying left ventricular myocardium metabolism in coronary artery disease, and in neurology for locating abnormal glucose metabolism related to epileptic seizures.
fludeoxyglucose f18
(Fludeoxyglucose F-18)
Biomedical Research Foundation of Northwest Louisiana
Usage: Fludeoxyglucose F 18 Injection is indicated for PET imaging in oncology to evaluate malignancies, in cardiology to identify residual glucose metabolism in coronary artery disease, and in neurology to locate abnormal glucose metabolism related to epileptic seizures.

Medications for Malignant Neoplasms

diazoxide

ethacrynate sodium

ethacrynic acid

fludeoxyglucose

fludeoxyglucose f 18

fludeoxyglucose f 18

fludeoxyglucose f 18

fludeoxyglucose f 18

fludeoxyglucose f-18

fludeoxyglucose f18